RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature's Toolbox, Inc. (NTx), a life sciences company enabling novel pharmaceutical RNA and protein development and production, today announced the expansion of its team with the appointments of Sheila Moran as Chief Commercial Officer, Phillip Easton, Ph.D. as Vice President of IT Infrastructure and Operations, and Lily Pisani as Senior Director of Customer Excellence.
“Nature’s Toolbox is on the verge of a major commercialization push that will take our proprietary technology out of the lab and into the global market,” said Jamie Coffin, Ph.D., CEO of NTx. “I worked with Sheila, Phillip, and Lily prior to joining NTx, and know they all have the right skills and experience to ensure NTx is set up for commercial success, bring in new customers, and drive financial growth.”
Sheila Moran, CCO, brings over 30 years of sales and business development experience in the healthcare and life sciences industries to Nature’s Toolbox. She most recently served as the Senior Vice President of Solution Sales at Sema4, where she led and directed sales, customer, and clinical support activities, including the establishment of commercial sales operations for the company’s genomic testing and data business. She delivered double-digit growth every quarter for over three years achieving more than 300% growth in the testing footprint in women’s health and oncology. Earlier in her career, she held leadership roles at Dell Healthcare and Life Sciences, and IBM Healthcare and Life Sciences.
“Biomanufacturing holds tremendous promise for the future of healthcare, as well as other industries. Nature’s Toolbox is uniquely positioned to lead this transformation with its combination of cutting-edge science, molecular design, and engineering prowess,” said Sheila Moran. “My background in technology and engineering within life sciences has prepared me for this exciting challenge of leading NTx into its commercialization phase alongside this amazingly talented team.”
Phillip Easton, Ph.D., VP of IT Infrastructure and Operations, brings over 30 years of IT services and business development leadership experience to help implement NTx’s IT strategy and operations. He most recently served as the Head of IT Services at Sema4, where he developed and implemented a company-wide IT strategy to support on-site and remote users and lab pipelines. During his time there, he was able to optimize resources and polices to realize $2M cost avoidance annually in technical expenses. Prior to Sema4, Phillip was a Business Development Manager at Dell Healthcare and Life Sciences where he developed solutions that resulted in $10 million in new hardware and software sales annually. Earlier in his career, he also worked in technical solutions for IBM Healthcare and Life Sciences.
Lily Pisani, Sr. Director of Customer Excellence, will oversee NTx’s sales and marketing strategies. She also comes to Nature’s Toolbox from Sema4, where she began as a Marketing Manager specializing in events. She worked her way up to the role of REI Regional Business Director, NY and NJ for the company’s women’s health portfolio, successfully maintaining and growing the second largest sales number in the country across all divisions. Lily has a proven track record of expanding startups’ brand recognition and has been recognized throughout her career for her ability to develop and execute effective sales and marketing campaigns, build strong relationships with customers, and drive revenue growth. Prior to Sema4, Lily held various marketing roles at CooperSurgical where she organized and executed customer events and managed logistics for CooperSurgical’s global tradeshow presence.
For more information about NTx and its proprietary platform, please visit: https://www.ntxbio.com.
About NTx
Nature's Toolbox, Inc. (NTx) is a life sciences company located in Rio Rancho, New Mexico. The company is commercializing its biomanufacturing systems NTxpress®, NTxscribe® and the bioinformatics platform, DruID, for the discovery of natural products. NTx’s proprietary continuous-flow, fully recombinant, in vitro, cell-free transcription system utilizes hollow fiber bioreactors to support the growing demand for mRNA-based vaccines and therapeutics. NTx’s biomanufacturing processes can easily be scaled to meet fluctuating supply needs so that companies can increase and streamline production as they respond to changing global demands. For more information, please visit: https://www.ntxbio.com.
